Johnson & ⁠Johnson is using artificial intelligence ⁠to slash by half the time it takes ​to generate new leads for developing ...

Johnson & Johnson has recently praised AI capabilities in work efficiency and production. The J&J group's company chief ...

At a Reuters conference earlier this year, Johnson & Johnson chief information officer Jim Swanson offered a striking number: ...

Key opportunities in the Global AI in Drug Discovery Market include leveraging AI to speed up drug development, reducing R&D ...

This figure illustrates three key applications of AI in antimicrobial drug development: (1) target identification and validation, including novel target discovery, affinity prediction, multi-target ...

Early-stage biologics discovery often focuses on binding affinity, while other developability attributes that affect ...

Johnson & Johnson says artificial intelligence has cut its drug lead optimization time by around 50%, while also slashing clinical trial report preparation from hundreds of hours to minutes. The ...

Barbara Slusher explains the hit-to-lead optimization process, high-throughput screening, and the role of AI and organoids in ...

Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage biotechnology company advancing precision oncology through its proprietary RADR ® AI platform, today announced the expansion of predictBBB.ai into ...

Discover how quality-driven drug development and AI accelerate safer medicines, reduce risk, and improve patient outcomes.

Global Drug Discovery Services Market OverviewThe global drug discovery services market is set to witness strong expansion, projected to grow at a CAGR of 15% from 2025 to 2030. This growth is ...

Drug repurposing could help find a treatment for multiple sulfatase deficiency, a rare genetic disease that currently has no ...